Repurposing a clinically approved prescription Colquhounia root tablet to treat diabetic kidney disease via suppressing PI3K/AKT/NF-kB activation
Abstract Background Growing clinical evidences show the potentials of Colquhounia root tablet (CRT) in alleviating diabetic kidney disease (DKD). However, its pharmacological properties and underlying mechanisms remain unclear. Methods 'Drug target-Disease gene' interaction network was con...
Saved in:
Main Authors: | Zhaochen Ma (Author), Yudong Liu (Author), Congchong Li (Author), Yanqiong Zhang (Author), Na Lin (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Colquhounia root tablet improves diabetic kidney disease by regulating epithelial-mesenchymal transition via the PTEN/PI3K/AKT pathway
by: Donghong Ma, et al.
Published: (2024) -
IGF-1 Facilitates Cartilage Reconstruction by Regulating PI3K/AKT, MAPK, and NF-kB Signaling in Rabbit Osteoarthritis
by: Hossain MA, et al.
Published: (2021) -
The role of NF-kB in the mechanisms of inflammation of the stomach's mucosa in children
by: V.І. Bobrova
Published: (2023) -
Characterization of NF-kB-mediated inhibition of catechol-<it>O</it>-methyltransferase
by: Conrad Matthew, et al.
Published: (2009) -
PI3K/AKT Pathway and Brain Malformations
by: Gavin B. Rice, et al.
Published: (2015)